At the same time, Medicare price negotiations under the Inflation Reduction Act finalized in November 2025
26 While the trial did not demonstrate a clinically significant benefit in reduction in HF hospitalization or cardiovascular death (hazard ratio, 0.87, 95% CI, 0.75-1.01), certain clinical subgroups including women and those with an EF on the lower side of the spectrum of EF demonstrated greater clinical benefit
Bullet-Point Conclusions : Core Compliance Leaders : Trummed Medical (Hangzhou) Co., Ltd
Bruce Alayof, Cardiovascular Disease 11
In fact, a recent study and release from the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society issued a statement that anyone who is taking a weight loss injectable with semaglutide and has a sharp or sudden loss of vision, should immediately stop taking the drug and get evaluated by a doctor
Start With a Provider-Led GLP-1 Program If you are ready to explore medically supervised weight-loss care, Independent Wellness makes it easy to begin